# Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument

> **NCT01847014** · PHASE3 · TERMINATED · sponsor: **Actelion** · enrollment: 4 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Macitentan

## Key facts

- **NCT ID:** NCT01847014
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09-01
- **Primary completion:** 2015-10-01
- **Final completion:** 2017-11-30
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Protocol-defined criterion of macitentan availability achieved.
- **Last updated:** 2018-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01847014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01847014, "Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01847014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*